|
|||||
|
|
Meaningful use stage 2 e-prescribing threshold and adverse drug events in the Medicare Part D population with diabetes |
|
| Authors: | Christopher Powers Meghan Hufstader Gabriel William Encinosa Farzad Mostashari Julie Bynum |
| Abstract: | |
| Keywords: | electronic prescribing adverse drug events Medicare Part D |